Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study

Gupte, Akshay N. and Kumar, Pavan and Araújo-Pereira, Mariana and Kulkarni, Vandana and Paradkar, Mandar and Pradhan, Neeta and Menon, Pradeep and Padmapriyadarsini, Chandrasekaran and Hanna, Luke-Elizabeth and Yogendra Shivakumar, Shri Vijay Bala and Rockwood, Neesha and Du Bruyn, Elsa and Karyakarte, Rajesh and Gaikwad, Sanjay and Bollinger, Robert and Golub, Jonathan and Gupte, Nikhil and Viswanathan, Vijay and Wilkinson, Robert J. and Mave, Vidya and Babu, Subash and Kornfeld, Hardy and Andrade, Bruno B. and Gupta, Amita (2021) Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study. European Respiratory Journal, 59 (4). p. 2100905. ISSN 0903-1936

Archive 202227.pdf - Published Version Download (699kB)

Affiliation:	ICMR-National Institute for Research in Tuberculosis
Item Type:	Article
URI:	http://eprints.nirt.res.in/id/eprint/1907

Actions (login required)

View Item